Neuroscience
4 Amino 2 thiabicyclo[3.1.0]hexane 4,6 Dicarboxylic Acid 2,2 Dioxide
8%
Amygdala
5%
Anhedonia
5%
Antidepressant
16%
Antipsychotic
50%
Arterial Spin Labeling
16%
Brain Areas
11%
DOPA
50%
Dopaminergic
37%
Dorsal Striatum
5%
Fluorine-18
50%
Frontal Lobe
25%
Gray Matter
12%
Gray Matter Volume
50%
Hippocampus
8%
In Vivo
12%
Ketamine
50%
Magnetic Resonance Imaging
12%
Magnetic Resonance Imaging
8%
Negative Syndrome
8%
Nucleus Accumbens
5%
Occipital Lobe
8%
Parietal Cortex
8%
Placebo
5%
Pomaglumetad Methionil
50%
Positive Syndrome
8%
positron emission tomographic scan
12%
Positron Emission Tomography
50%
Prefrontal Cortex
37%
Psychotomimetic
5%
Putamen
5%
Striatum
16%
Treatment-Resistant Schizophrenia
12%
Ventral Striatum
5%
Ventral Tegmental Area
11%
Voxel-Based Morphometry
50%
Pharmacology, Toxicology and Pharmaceutical Science
4 Amino 2 thiabicyclo[3.1.0]hexane 4,6 Dicarboxylic Acid 2,2 Dioxide
8%
Alanine
8%
Antidepressant
16%
Aspartic Acid
8%
Biological Marker
8%
Drug Administration
5%
Glutamic Acid
16%
Ketamine
100%
Metabotropic Receptor 2
8%
Metabotropic Receptor Agonist
50%
Methionine
8%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
8%
Normal Human
50%
Placebo
13%
Pomaglumetad Methionil
50%
Prodrug
50%
Psychotomimetic
5%
Receptor
8%
Remission
50%
